| P50 | author | Andrea Fagiolini | Q42651594 |
| P2093 | author name string | Jane Chang | |
| | Isabella Soreca | |
| | K N Roy Chengappa | |
| P2860 | cites work | Obesity, Metabolic Syndrome, and Cardiovascular Disease | Q22241664 |
| | Prevalence and Trends in Obesity Among US Adults, 1999-2000 | Q22253005 |
| | The impact of obesity on health-related quality-of-life in the general adult US population. | Q51931288 |
| | Glucose-induced increase in memory performance in patients with schizophrenia. | Q52032929 |
| | Complicated mania. Comorbidity and immediate outcome in the treatment of mania. | Q52071062 |
| | Components of the "metabolic syndrome" and incidence of type 2 diabetes. | Q53957584 |
| | Smoking induces insulin resistance--a potential link with the insulin resistance syndrome. | Q54243711 |
| | The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. | Q55331780 |
| | The continuing epidemics of obesity and diabetes in the United States | Q56890709 |
| | Predictors of immediate response in the treatment of mania: The importance of comorbidity | Q57697317 |
| | Clinical correlates of current level of functioning in primary care-treated bipolar patients | Q57849268 |
| | Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 |
| | Clinical significance of reversed vegetative subtypes of recurrent major depression | Q67928286 |
| | Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder | Q71100927 |
| | High plasma norepinephrine levels in patients with major affective disorder | Q72955610 |
| | Prevalence of overweight and obesity in bipolar patients | Q73805994 |
| | Mortality of patients with mood disorders: follow-up over 34-38 years | Q74294155 |
| | The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men | Q77758565 |
| | Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia | Q79731969 |
| | The increasing medical burden in bipolar disorder | Q81782161 |
| | Does treating subclinical hypothyroidism improve markers of cardiovascular risk? | Q82852176 |
| | Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs | Q45285400 |
| | Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program | Q46319819 |
| | The effect of somatic treatment and comorbidity on immediate outcome in manic patients | Q46645696 |
| | Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 |
| | Measured and expected resting energy expenditure in patients with bipolar disorder on maintenance treatment | Q46910752 |
| | Weight gain occurs after onset of bipolar illness in overweight bipolar patients | Q47310353 |
| | Performance of a weight-related measure of Quality of Life in a psychiatric sample | Q47337805 |
| | Lithium treatment and weight gain | Q47341854 |
| | Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder | Q47345706 |
| | Metabolic changes during treatment with valproate in humans: implication for untoward weight gain | Q47411038 |
| | Clinical features of bipolar disorder with and without comorbid diabetes mellitus | Q47629610 |
| | Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients | Q48114087 |
| | Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men. | Q48320434 |
| | Psychoneuroendocrinology of mood disorders. The hypothalamic-pituitary-thyroid axis | Q48427610 |
| | The economic impact of bipolar disorder in an employed population from an employer perspective. | Q50788759 |
| | Relationship between bipolar illness and binge-eating disorders. | Q50967629 |
| | Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. | Q51485990 |
| | Hypothyroidism in patients with bipolar I disorder treated primarily with lithium. | Q51914417 |
| | A rating scale for depression | Q24564540 |
| | From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase | Q24685521 |
| | A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study | Q24799886 |
| | Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities | Q24806762 |
| | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 |
| | Metabolic issues and cardiovascular disease in patients with psychiatric disorders | Q28251670 |
| | Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial | Q28259736 |
| | Obesity | Q28275029 |
| | Lithium inhibits hepatic gluconeogenesis and phosphoenolpyruvate carboxykinase gene expression | Q28316091 |
| | Lifetime Health and Economic Consequences of Obesity | Q29543776 |
| | Selected major risk factors and global and regional burden of disease | Q29614888 |
| | Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 |
| | Using drug claims data to assess the relationship of medication adherence with hospitalization and costs | Q30652843 |
| | The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. | Q30887060 |
| | Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial | Q31048788 |
| | Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment | Q33604144 |
| | Early onset of lithium-associated hypothyroidism | Q33921211 |
| | Reward deficiency syndrome: genetic aspects of behavioral disorders | Q33927226 |
| | Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome | Q33936978 |
| | Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 |
| | Weight gain and antidepressants | Q33990858 |
| | Antipsychotic-induced weight gain: a review of the literature | Q34247423 |
| | Consensus development conference on antipsychotic drugs and obesity and diabetes | Q34293049 |
| | The obesity epidemic, metabolic syndrome and future prevention strategies | Q34323455 |
| | Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34338064 |
| | Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? | Q34361973 |
| | Management of comorbid bipolar disorder and substance abuse. | Q34564694 |
| | Obesity and diabetes in the developing world--a growing challenge | Q34603178 |
| | Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 |
| | Incurring greater health care costs: risk stratification of employees with bipolar disorder | Q34795108 |
| | An economic evaluation of manic-depressive illness--1991. | Q34993493 |
| | Health care utilization and costs among privately insured patients with bipolar I disorder | Q35041602 |
| | Weight gain in the treatment of mood disorders | Q35189343 |
| | Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. | Q35631515 |
| | Psychiatric and medical comorbidities of bipolar disorder | Q36021272 |
| | Atypical antipsychotics and glucose homeostasis. | Q36091769 |
| | Hypothalamic-pituitary-adrenal axis and bipolar disorder. | Q36096503 |
| | Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications | Q36216515 |
| | Neural bases of food-seeking: affect, arousal and reward in corticostriatolimbic circuits. | Q36300456 |
| | The burden of general medical conditions in patients with bipolar disorder | Q36327280 |
| | The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. | Q36349761 |
| | Emerging treatments for bipolar disorder: safety and adverse effect profiles | Q36364980 |
| | The obesity epidemic and its cardiovascular consequences | Q36497939 |
| | Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model | Q36539425 |
| | Associations between bipolar disorder and metabolic syndrome: A review. | Q36556666 |
| | Links between nutrition, drug abuse, and the metabolic syndrome | Q36653970 |
| | Thyroid dysfunction and serum lipids: a community-based study. | Q38439894 |
| | Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis | Q38722717 |
| | Use of general medical services by VA patients with psychiatric disorders | Q38955536 |
| | Cardiovascular morbidity and mortality associated with the metabolic syndrome | Q39513407 |
| | The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men | Q39513420 |
| | Increasing prevalence of the metabolic syndrome among u.s. Adults. | Q40479545 |
| | Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. | Q40555955 |
| | Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1. | Q42459147 |
| | A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 |
| | A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes | Q42627987 |
| | Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 |
| | Determinants of overweight and obesity in patients with bipolar disorder. | Q43683014 |
| | Electrodermal activity in young adults at genetic risk for affective disorder | Q44185152 |
| | The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype | Q44207549 |
| | Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study | Q44225823 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older | Q44418730 |
| | Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 |
| | The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients | Q44496541 |
| | Reward without dopamine. | Q44674159 |
| | Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions | Q44752429 |
| | Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women | Q44907712 |
| | Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder | Q44917858 |
| | Burden of general medical conditions among individuals with bipolar disorder | Q45070754 |
| | Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study | Q45077947 |
| | Cardiovascular risk factors in outpatients with bipolar disorder | Q45095376 |
| | The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective | Q45135891 |
| | The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. | Q45254387 |
| P433 | issue | 8 | |
| P921 | main subject | bipolar disorder | Q131755 |
| | metabolic syndrome | Q657193 |
| P304 | page(s) | 655-669 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden | |
| P478 | volume | 22 | |